S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Fusion Pharmaceuticals (FUSN) Insider Trading & Ownership

$12.14
-0.91 (-6.97%)
(As of 04:00 PM ET)

Fusion Pharmaceuticals (NASDAQ:FUSN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.75%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$161,335.71
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$517,191.81
Get FUSN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Fusion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FUSN Insider Buying and Selling by Quarter


Fusion Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/11/2022Steven GannonDirectorBuy44,400$2.03$90,132.00  
4/27/2022John ValliantCEOSell4,511$6.03$27,201.33  
4/25/2022John ValliantCEOSell2,036$6.03$12,277.08  
4/20/2022John ValliantCEOSell367$6.02$2,209.34  
4/13/2022John ValliantCEOSell11,994$6.41$76,881.54  
4/11/2022John ValliantCEOSell2,600$7.37$19,162.00  
4/8/2022John ValliantCEOSell826$7.52$6,211.52  
4/6/2022John ValliantCEOSell100$7.58$758.00  
3/30/2022John ValliantCEOSell300$7.52$2,256.00  
3/28/2022John ValliantCEOSell9,600$7.55$72,480.00  
3/25/2022John ValliantCEOSell500$7.42$3,710.00  
3/23/2022John ValliantCEOSell100$7.50$750.00  
3/21/2022John ValliantCEOSell1,500$7.47$11,205.00  
3/17/2022John ValliantCEOSell900$7.51$6,759.00  
3/7/2022John ValliantCEOSell3,100$6.99$21,669.00  
3/4/2022John ValliantCEOSell8,400$7.32$61,488.00  
2/28/2022John ValliantCEOSell3,100$7.40$22,940.00  
2/24/2022John ValliantCEOSell2,500$7.41$18,525.00  
2/22/2022John ValliantCEOSell4,100$7.85$32,185.00  
2/17/2022John ValliantCEOSell1,700$7.98$13,566.00  
2/15/2022John ValliantCEOSell12,600$8.33$104,958.00  
8/23/2021Steven GannonDirectorBuy2,829$7.99$22,603.71  
8/16/2021Steven GannonDirectorBuy6,000$8.10$48,600.00  
(Data available from 1/1/2013 forward)












FUSN Insider Trading Activity - Frequently Asked Questions

Who is on Fusion Pharmaceuticals's Insider Roster?

The list of insiders at Fusion Pharmaceuticals includes John Valliant, and Steven Gannon. Learn more on insiders at FUSN.

What percentage of Fusion Pharmaceuticals stock is owned by insiders?

7.75% of Fusion Pharmaceuticals stock is owned by insiders. Learn more on FUSN's insider holdings.

Which Fusion Pharmaceuticals insiders have been buying company stock?

The following insider purchased FUSN shares in the last 24 months: Steven Gannon ($90,132.00).

How much insider buying is happening at Fusion Pharmaceuticals?

Insiders have purchased a total of 44,400 FUSN shares in the last 24 months for a total of $90,132.00 bought.

Which Fusion Pharmaceuticals insiders have been selling company stock?

The following insider sold FUSN shares in the last 24 months: John Valliant ($366,482.81).

How much insider selling is happening at Fusion Pharmaceuticals?

Insiders have sold a total of 52,434 Fusion Pharmaceuticals shares in the last 24 months for a total of $366,482.81 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:FUSN) was last updated on 2/23/2024 by MarketBeat.com Staff